Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): A clinicopathological study emphasizing extrarenal PEComas

Histopathology

Volumn 62, Issue 4, 2013, Pages 642-650

  Rao, Qiu ^a   Cheng, Liang ^b   Xia, Qiu yuan ^a   Liu, Biao ^a   Li, Li ^a   Shi, Qun li ^a   Shi, Shan shan ^a   Yu, Bo ^a   Zhang, Ru song ^a   Ma, Heng hui ^a   Lu, Zhen feng ^a   Tu, Pin ^a   Zhou, Xiao jun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiomyolipoma; Cathepsin K; Immunohistochemistry; PEComa; Tuberous sclerosis

Indexed keywords

CATHEPSIN K; MELAN A; MONOCLONAL ANTIBODY HMB 45; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E3; UNCLASSIFIED DRUG;

ABDOMINAL TUMOR; ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; PERIVASCULAR EPITHELIOID CELL TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS TISSUE; SUBCUTANEOUS TISSUE TUMOR; UTERUS TUMOR;

ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BROAD LIGAMENT; CATHEPSIN K; CELL COUNT; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PERIVASCULAR EPITHELIOID CELL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84874195401     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12059     Document Type: Article

References (37)

1. Hornick JL, Fletcher CD. Pecoma: what do we know so far? Histopathology 2006; 48; 75-82.
2. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. Pecomas: the past, the present and the future. Virchows Arch. 2008; 452; 119-132.
3. Armah HB, Parwani AV. Perivascular epithelioid cell tumor. Arch. Pathol. Lab. Med. 2009; 133; 648-654.
4. Sukov WR, Cheville JC, Amin MB, Gupta R, Folpe AL. Perivascular epithelioid cell tumor (pecoma) of the urinary bladder: report of 3 cases and review of the literature. Am. J. Surg. Pathol. 2009; 33; 304-308.
5. Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum. Pathol. 2010; 41; 1-15.
6. Yamashita K, Fletcher CD. Pecoma presenting in bone: clinicopathologic analysis of 6 cases and literature review. Am. J. Surg. Pathol. 2010; 34; 1622-1629.
7. Chan JK, Tsang WY, Pau MY, Tang MC, Pang SW, Fletcher CD. Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle. Histopathology 1993; 22; 445-455.
8. Matsui K, Tatsuguchi A, Valencia J et al. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum. Pathol. 2000; 31; 1242-1248.
9. Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest 1998; 114; 1689-1703.
10. Folpe AL, Goodman ZD, Ishak KG et al. Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres: a novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults. Am. J. Surg. Pathol. 2000; 24; 1239-1246.
11. Tazelaar HD, Batts KP, Srigley JR. Primary extrapulmonary sugar tumor (PEST): a report of four cases. Mod. Pathol. 2001; 14; 615-622.
12. Vang R, Kempson RL. Perivascular epithelioid cell tumor ('pecoma') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am. J. Surg. Pathol. 2002; 26; 1-13.
13. Genevay M, Mc Kee T, Zimmer G, Cathomas G, Guillou L. Digestive pecomas: a solution when the diagnosis fails to 'Fit'. Ann. Diagn. Pathol. 2004; 8; 367-372.
14. Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am. J. Surg. Pathol. 2005; 29; 1558-1575.
15. Mentzel T, Reisshauer S, Rutten A, Hantschke M, Soares de Almeida LM, Kutzner H. Cutaneous clear cell myomelanocytic tumour: a new member of the growing family of perivascular epithelioid cell tumours (pecomas). Clinicopathological and immunohistochemical analysis of seven cases. Histopathology 2005; 46; 498-504.
16. Kenerson H, Folpe AL, Takayama TK, Yeung RS. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum. Pathol. 2007; 38; 1361-1371.
17. Righi A, Dimosthenous K, Rosai J. Pecoma: another member of the mit tumor family? Int. J. Surg. Pathol. 2008; 16; 16-20.
18. Tanaka M, Kato K, Gomi K et al. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma. Am. J. Surg. Pathol. 2009; 33; 1416-1420.
19. Kuroda N, Goda M, Kazakov DV, Hes O, Michal M, Lee GH. Perivascular epithelioid cell tumor of the nasal cavity with TFE3 expression. Pathol. Int. 2009; 59; 769-770.
20. Wen MC, Jan YJ, Li MC, Wang J, Lin A. Monotypic epithelioid angiomyolipoma of the liver with TFE3 expression. Pathology 2010; 42; 300-302.
21. Dickson BC, Brooks JS, Pasha TL, Zhang PJ. TFE3 expression in tumors of the microphthalmia-associated transcription factor (MITF) family. Int. J. Surg. Pathol. 2011; 19; 26-30.
22. Argani P, Aulmann S, Illei PB et al. A distinctive subset of pecomas harbors TFE3 gene fusions. Am. J. Surg. Pathol. 2010; 34; 1395-1406.
23. Davis IJ, Fisher DE. MIT transcription factor associated malignancies in man. Cell Cycle 2007; 6; 1724-1729.
24. Medendorp K, van Groningen JJ, Schepens M et al. Molecular mechanisms underlying the MIT translocation subgroup of renal cell carcinomas. Cytogenet. Genome Res. 2007; 118; 157-165.
25. Haq R, Fisher DE. Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. J. Clin. Oncol. 2011; 29; 3474-3482.
26. Motyckova G, Weilbaecher KN, Horstmann M, Rieman DJ, Fisher DZ, Fisher DE. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl Acad. Sci. USA 2001; 98; 5798-5803.
27. Martignoni G, Pea M, Gobbo S et al. Cathepsin-K immunoreactivity distinguishes MITF/TFE family renal translocation carcinomas from other renal carcinomas. Mod. Pathol. 2009; 22; 1016-1022.
28. Martignoni G, Bonetti F, Chilosi M et al. Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Mod. Pathol. 2012; 25; 100-111.
29. Cuatrecasas M, Catasus L, Palacios J, Prat J. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am. J. Surg. Pathol. 2009; 33; 556-567.
30. Zhong M, De Angelo P, Osborne L et al. Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of xp11 translocation renal cell carcinoma and alveolar soft part sarcoma. Am. J. Surg. Pathol. 2010; 34; 757-766.
31. Hornick JL, Fletcher CD. Sclerosing pecoma: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum. Am. J. Surg. Pathol. 2008; 32; 493-501.
32. Matsuyama A, Hisaoka M, Ichikawa K et al. Sclerosing variant of epithelioid angiomyolipoma. Pathol. Int. 2008; 58; 306-310.
33. Yamada Y, Yamamoto H, Ohishi Y et al. Sclerosing variant of perivascular epithelioid cell tumor in the female genital organs. Pathol. Int. 2011; 61; 768-772.
34. Santi R, Franchi A, Villari D et al. Sclerosing variant of pecoma: report of a case and review of the literature. Histol. Histopathol. 2012; 27; 1175-1181.
35. Rao Q, Liu B, Cheng L et al. Renal cell carcinomas with t(6;11)(p21;q12): a clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization. Am. J. Surg. Pathol. 2012; 36; 1327-1338.
36. Cho HY, Chung DH, Khurana H, Zhai QJ, Ro JY. The role of TFE3 in pecoma. Histopathology 2008; 53; 236-249.
37. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 2003; 27; 750-761.